AstraZeneca reels in $500M from two China deals

AstraZeneca signed two product deals valued at $500 million with China Medical System Holdings Ltd., a pharmaceutical products service provider based in Shenzhen, China...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.